Literature DB >> 30121212

Gymnotic delivery and gene silencing activity of reduction-responsive siRNAs bearing lipophilic disulfide-containing modifications at 2'-position.

Florian Gauthier1, Sandra Claveau2, Jean-Rémi Bertrand2, Jean-Jacques Vasseur1, Christelle Dupouy1, Françoise Debart3.   

Abstract

Modified oligoribonucleotides used as siRNAs bearing biolabile disulfide-containing groups at some 2'-positions were synthesized following a post-synthesis transformation of solid-supported 2'-O-acetylthiomethyl RNA, previously described. Thus, the reduction-responsive and lipophilic benzyldithiomethyl (BnSSM) modification was introduced at different locations into siRNAs targeting the Ewing sarcoma EWS-Fli1 protein. Thermal stability, serum stability and response to glutathione treatment of modified siRNAs were thoroughly investigated. Among 17 modified siRNAs, significant gene silencing activities were demonstrated for the 8 most stable siRNAs in serum (half-life > 1 h) when using a transfection reagent. Of special interest, two naked 2'-O-BnSSM siRNAs transfection exhibited a remarkable gene silencing activity after 24 h incubation. These inhibitions are consistent with an efficient gymnotic delivery demonstrated by the presence of the corresponding fluorescent siRNAs within cells.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Disulfide-containing groups; Gene silencing; Gymnotic delivery; Reduction-responsive; siRNA

Mesh:

Substances:

Year:  2018        PMID: 30121212     DOI: 10.1016/j.bmc.2018.07.033

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

Review 1.  Novel Targeted Therapeutic Strategies for Ewing Sarcoma.

Authors:  Daria Fayzullina; Sergey Tsibulnikov; Mikhail Stempen; Brett A Schroeder; Naveen Kumar; Rajesh Kumar Kharwar; Arbind Acharya; Peter Timashev; Ilya Ulasov
Journal:  Cancers (Basel)       Date:  2022-04-14       Impact factor: 6.575

2.  Tetrazine-Induced Bioorthogonal Activation of Vitamin E-Modified siRNA for Gene Silencing.

Authors:  Xueli Zhang; Amu Gubu; Jianfei Xu; Ning Yan; Wenbo Su; Di Feng; Qian Wang; Xinjing Tang
Journal:  Molecules       Date:  2022-07-08       Impact factor: 4.927

3.  Conjugation of Doxorubicin to siRNA Through Disulfide-based Self-immolative Linkers.

Authors:  Florian Gauthier; Jean-Rémi Bertrand; Jean-Jacques Vasseur; Christelle Dupouy; Françoise Debart
Journal:  Molecules       Date:  2020-06-11       Impact factor: 4.411

4.  Postsynthetic On-Column 2' Functionalization of RNA by Convenient Versatile Method.

Authors:  Olga A Krasheninina; Veniamin S Fishman; Alexander A Lomzov; Alexey V Ustinov; Alya G Venyaminova
Journal:  Int J Mol Sci       Date:  2020-07-20       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.